Western Oncolytics
Biotechnology, 240 Alpha Dr, Pittsburgh, Pennsylvania, 15238, United States, 11-50 Employees
Who is WESTERN ONCOLYTICS
Western Oncolytics was founded in 2014 to bring cutting-edge, next-generation oncolytic immunotherapies to cancer patients everywhere. Spun out of University of Pittsburghs world-class on...
Read More
-
Headquarters: 240 Alpha Dr, Pittsburgh, Pennsylvania, 15238, United States
-
Date Founded: 2014
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 999990 |
Show More
Does something look wrong? Fix it. | View contact records from WESTERN ONCOLYTICS
Western Oncolytics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Western Oncolytics
Answer: Western Oncolytics's headquarters are located at 240 Alpha Dr, Pittsburgh, Pennsylvania, 15238, United States
Answer: Western Oncolytics's official website is https://westernoncolytics.com
Answer: Western Oncolytics's revenue is $5 Million to $10 Million
Answer: Western Oncolytics's SIC: 2836
Answer: Western Oncolytics's NAICS: 999990
Answer: Western Oncolytics has 11-50 employees
Answer: Western Oncolytics is in Biotechnology
Answer: Western Oncolytics contact info: Phone number: Website: https://westernoncolytics.com
Answer: Western Oncolytics was founded in 2014 to bring cutting-edge, next-generation oncolytic immunotherapies to cancer patients everywhere. Spun out of University of Pittsburghs world-class oncolytic virus and immunotherapy research programs, our company is now advancing multiple therapeutic candidates towards the clinic and occupies over 18,000 square feet of lab space in our Pittsburgh headquarters. We are engineering an optimized vaccinia virus-based oncolytic platform which can be combined with multiple transgenes to create versatile and differentiated immunotherapies. Our development programs are designed to be safe, potent, and systemically deliverable to treat cancer patients across a variety of tumor types. In 2016, we formed a strategic partnership with Pfizer for our lead preclinical program, WO-12.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month